State by State Crackdown on Hemp

CURE8 BLOG

State-by-State Crackdown on Hemp – What It Means for the Future of Cannabis and Hemp Operators

In recent months, several U.S. states have enacted stricter regulations on hemp-derived products, signaling a significant shift that has profound implications for the broader cannabis industry. What was once seen as a federal loophole allowing for the legal sale of hemp derivatives, including popular cannabinoids like Delta-8 and Delta-10 THC, is now facing a wave of state-level restrictions that challenge the current hemp landscape.

Since the 2018 Farm Bill federally legalized hemp with a THC limit of 0.3% Delta-9 THC, hemp has flourished as a separate but related market to the cannabis industry. This distinction has enabled rapid innovation, allowing operators to produce alternative cannabinoids and THC isomers that mimic the psychoactive effects of traditional cannabis. However, with inconsistent regulation, states are taking their own approaches to address the complexities of this evolving market.

For industry stakeholders — from licensed cannabis operators to hemp producers and consumers alike — understanding these changes is crucial. The emerging wave of restrictions represents more than just a crackdown on products; it reflects broader concerns about consumer safety, regulatory gaps, and the growing overlap between the hemp and cannabis sectors. This article explores which hemp-derived products are being targeted, the states leading these efforts, and the impact of this regulatory shift on the future of cannabis and hemp operators nationwide.

What Hemp Products Are Being Targeted, and in Which States? 

Overview of Targeted Products

As states grapple with regulating the fast-evolving hemp market, certain hemp-derived products are increasingly coming under scrutiny. The primary targets of these regulations are cannabinoids like Delta-8 THC, Delta-10 THC, and THC-O — all derived from hemp but capable of producing psychoactive effects similar to traditional cannabis. States are also focusing on synthetic cannabinoids and compounds modified in ways that blur the line between hemp and cannabis products.

Map of Affected States

The map below provides a visual overview of the states that have introduced or implemented regulations targeting certain hemp-derived products, especially those containing cannabinoids like Delta-8 THC, Delta-10 THC, and synthetic compounds such as THC-O. As expanded in the later sections, each highlighted state has approached regulation differently, with some opting for total bans on synthetic cannabinoids, others enforcing THC potency limits, and several focusing on labeling requirements and age restrictions.

State-by-State Breakdown

Here is a breakdown of some of the key states initiating these regulations and what they entail:

Minnesota

In Minnesota, regulatory attention has been focused on THC content in hemp products. Although the state allows the sale of products derived from industrial hemp, potency restrictions are in place to limit the amount of THC per serving and per package, targeting products like Delta-8 THC that can mimic the effects of marijuana. These restrictions are designed to maintain safety while allowing some market growth for hemp operators.

Tennessee

Cannabis with a concentration of less than 0.3% delta-9 THC is defined as legal hemp in Tennessee – and federally. Cannabis with concentrations greater than 0.3% is classified as marijuana and is illegal to grow, sell or possess in Tennessee.

North Carolina

North Carolina’s approach involves age restrictions and stringent compliance for Delta-8 THC products. While the state has not enacted a full ban on these products, operators must adhere closely to federal potency limits, and only individuals over a specified age can purchase them. The goal is to control the sale of intoxicating products, particularly those appealing to younger consumers.

South Dakota

In South Dakota, House Bill 1125 has placed a more restrictive stance on synthetic cannabinoids, effectively banning chemically modified hemp-derived products like Delta-8 and THC-O. This legislative move, enacted in early 2024, eliminates the sale of any cannabinoids that have been chemically altered, setting a hard line between traditional hemp and cannabis products in South Dakota. This measure aims to address safety concerns tied to the unregulated modification of hemp compounds.

Louisiana

Louisiana’s restrictions primarily target THC potency and age accessibility in hemp products. Legislation now limits THC content to 8 mg per serving and enforces strict age restrictions, prohibiting sales to individuals under 21. This impacts the availability of Delta-8 THC and similar products while allowing other, less intoxicating hemp derivatives. The state’s measures reflect a cautious but open stance, balancing market availability with consumer protection.

California

In late 2024, California introduced emergency regulations targeting the sale of hemp-derived products containing detectable levels of intoxicating cannabinoids, such as Delta-8 and Delta-10 THC. These regulations prohibit the sale of any hemp product capable of producing psychoactive effects, effectively eliminating many popular hemp-derived cannabinoids from the market. Furthermore, the state has imposed a strict minimum purchase age of 21 to prevent youth access.

Illinois

Illinois has proposed a series of legislative changes aimed at tightening control over Delta-8 and Delta-10 THC products. The focus is on preventing minors from accessing these intoxicating hemp-derived cannabinoids, which are often sold in appealing forms like gummies, candies, and vape cartridges. Proposed measures include stricter age restrictions, detailed labeling requirements, and potency caps to limit the psychoactive effects of these products. Illinois lawmakers are also exploring ways to enhance testing standards to ensure product safety and transparency. This approach reflects the state’s effort to bridge regulatory gaps and protect consumers while maintaining a fair market for licensed cannabis operators.

Other States: Iowa, Nebraska, New York, Colorado, Oregon, Kentucky, Texas

Across these states, a variety of restrictions and regulatory approaches are being implemented, often with an emphasis on federal compliance, labeling requirements, and age restrictions. Iowa, for example, allows edible hemp products but limits the amount of THC per serving to reduce potential intoxication effects. Nebraska has continued to allow non-intoxicating hemp products within federal guidelines, while New York and Colorado have introduced labeling and compliance protocols for any consumable hemp products. Oregon has taken a more temporary approach, enacting a moratorium on new licenses while enforcing stricter registration for any hemp-derived cannabinoids.

With each state responding differently to the rising presence of these hemp derivatives, the overall trend is clear: many states are working to either limit or regulate the availability of Delta-8 THC, Delta-10 THC, and other novel cannabinoids, especially those that produce psychoactive effects. For operators, the shifting regulatory environment requires careful attention to state-specific rules and proactive adaptation to stay compliant in an increasingly regulated market.

Why Are States Cracking Down on Hemp-Derived Products?

The recent wave of state-level crackdowns on hemp-derived products reflects growing concerns over public health, regulatory inconsistencies, and economic pressure from the cannabis industry. Each of these factors has contributed to a complex regulatory environment that hemp operators and cannabis businesses alike must navigate as states impose tighter controls on hemp-derived cannabinoids like Delta-8 THC, Delta-10 THC, and other synthetic compounds.

Public Health Concerns

One of the primary drivers behind state crackdowns is concern over public health and safety. Hemp-derived products, particularly synthetic cannabinoids like Delta-8 THC, are increasingly popular due to their availability and effects similar to traditional marijuana. However, because these products are often not subject to the same rigorous testing standards as traditional cannabis, they can pose risks related to product purity, potency, and labeling accuracy. Mislabeling is a major issue; some products may contain levels of THC or other cannabinoids that differ significantly from what is advertised, posing a risk to unsuspecting consumers, particularly young people.

States are particularly focused on preventing youth access to these intoxicating cannabinoids, many of which are marketed in forms appealing to younger demographics, such as gummies, vape cartridges, and candies. To address these concerns, states are implementing restrictions like age limits, potency caps, and packaging requirements aimed at reducing youth access and protecting public health.

Regulatory Gaps and Market Demand

Another critical factor contributing to these crackdowns is the regulatory gap between federal and state laws, which has allowed hemp-derived cannabinoids to enter the market with minimal oversight. The 2018 Farm Bill federally legalized hemp and its derivatives with less than 0.3% Delta-9 THC, but it did not address the legal status of other cannabinoids like Delta-8 THC. This regulatory ambiguity has led to a surge of hemp-derived products that fall into a “legal gray area.” As demand grows for alternatives to traditional marijuana products, states are finding themselves at a crossroads between allowing market innovation and ensuring consumer safety.

Due to the lack of federal guidance, states are stepping in to close these regulatory gaps by creating their own rules. Some states are capping allowable THC levels across all cannabinoids, while others are prohibiting the sale of chemically modified cannabinoids altogether. This state-led regulation creates a patchwork of rules that can be challenging for operators, particularly those selling across state lines.

Pressure from the Cannabis Industry

Traditional cannabis operators, who face strict regulatory requirements, are also pressuring state lawmakers to impose similar rules on hemp-derived products, especially those with psychoactive effects. Licensed cannabis businesses argue that the availability of unregulated or loosely regulated hemp-derived alternatives creates an uneven playing field. These hemp products often avoid the rigorous testing, labeling, and compliance protocols that traditional cannabis businesses must follow, allowing them to compete in markets where cannabis is either highly regulated or still illegal.

This economic pressure has contributed to a growing call for stricter state laws, as cannabis businesses push for regulatory standards that would reduce competition from hemp-derived products. By supporting tighter restrictions, licensed cannabis operators hope to limit competition and ensure that the cannabis industry operates under uniform safety and quality standards across both marijuana and hemp sectors.

The crackdown on hemp-derived products addresses public health risks, regulatory gaps, and economic pressures from traditional cannabis businesses. As states enforce targeted restrictions, hemp and cannabis operators must adapt to this evolving regulatory landscape.

Why Is This Crackdown Happening Now? 

The current wave of state-level crackdowns on hemp-derived products is no coincidence. A combination of evolving market dynamics, soaring consumer demand, and the absence of clear federal guidance has created a perfect storm that has prompted states to step in and establish their own rules. As a result, many states are now enacting stricter regulations on Delta-8 THC, Delta-10 THC, and other hemp-derived cannabinoids, reflecting the fast-paced shifts in the cannabis and hemp markets. 

Evolving Market Dynamics

Since the federal legalization of hemp in the 2018 Farm Bill, the hemp market has grown exponentially. The separation of hemp (defined as cannabis containing less than 0.3% Delta-9 THC) from marijuana has allowed hemp producers to develop innovative cannabinoid products that can be marketed and sold legally, even in states where marijuana remains illegal. This has spurred a significant rise in the production of hemp-derived cannabinoids, many of which offer psychoactive effects similar to those of traditional cannabis.

However, this rapid market expansion has led to increasing regulatory scrutiny. States are grappling with how to manage a market that includes products like Delta-8 and Delta-10, which were not explicitly covered in the 2018 Farm Bill. As the hemp and cannabis markets continue to expand, states are reassessing their regulations to ensure consumer safety and address the potential for unregulated psychoactive products to slip through legal loopholes.

Increased Consumer Demand for Alternative Cannabinoids

Consumer interest in alternative cannabinoids like Delta-8 and Delta-10 has skyrocketed in recent years. These products offer a psychoactive experience similar to that of traditional cannabis but are derived from federally legal hemp. As a result, they have become popular alternatives in regions where cannabis is not yet legal. The ease of access and variety of product types, such as gummies, vape cartridges, and tinctures, have contributed to a surge in demand for these hemp-derived cannabinoids. 

The rising popularity of these products, however, has prompted states to evaluate their potential risks and take regulatory action. Without consistent oversight, some hemp-derived products have been found to contain unlisted or mislabeled cannabinoid levels, presenting risks to consumer safety. This high demand, coupled with concerns about product integrity, has led states to create new regulations to safeguard consumers and ensure that intoxicating hemp products are managed responsibly. 

Federal Inaction and State Response

Despite the growth of the hemp industry, there has been limited federal guidance on how states should handle hemp-derived cannabinoids beyond the 2018 Farm Bill’s THC limit of 0.3% for Delta-9 THC. This lack of comprehensive federal regulation has forced states to step in, each creating its own rules to address the complexities of these new products. In many cases, state lawmakers have been compelled to react quickly to the proliferation of unregulated cannabinoids in local markets, leading to a diverse and fragmented regulatory landscape. 

In the absence of clear federal guidelines, states are taking varied approaches: some are implementing outright bans on certain hemp-derived cannabinoids, while others are introducing strict labeling and testing requirements. For states with mature cannabis markets, this move is also a means to protect their existing regulatory frameworks and licensed cannabis businesses. The response of states to federal inaction is an indicator of the pressure on lawmakers to address the challenges of managing an industry that is both rapidly expanding and innovating. 

The crackdown is driven by rapid market growth, high demand for alternative cannabinoids, and limited federal regulation. This state-led response underscores the need for hemp and cannabis operators to adapt to the shifting regulatory landscape. 

Impact on the Cannabis Industry: Is It Good or Bad for Operators? 

The recent regulatory changes surrounding hemp-derived products have prompted a complex dialogue within the cannabis industry, raising questions about the balance between consumer safety and market competition. As states crack down on products like Delta-8 THC and Delta-10 THC, operators must assess how these new regulations will influence their business strategies. While some operators may find opportunities in a more regulated environment, others may face challenges adapting to the evolving landscape. This duality highlights the importance of understanding both the potential advantages and the difficulties posed by these state-level changes. 

Benefits for Traditional Cannabis Operators

The increasing regulations on hemp-derived cannabinoids may provide key advantages for traditional cannabis operators by limiting competition from unlicensed products. Until recently, products like Delta-8 THC and Delta-10 THC could be marketed in a relatively unregulated space, allowing unlicensed sellers to bypass the stricter standards and higher tax rates that cannabis dispensaries must follow. By restricting or banning these intoxicating hemp products, states are effectively redirecting consumers toward licensed cannabis dispensaries, which often boast higher levels of testing and quality control. This shift could help stabilize the market and offer cannabis operators a more level playing field. 

Additionally, as states take a stronger stance on unregulated hemp products, consumer trust in the licensed cannabis industry may improve. Unlike hemp-derived cannabinoids, which lack consistent quality and safety oversight, licensed cannabis products undergo rigorous testing and compliance checks. This quality assurance may increase consumer confidence in dispensary products, further enhancing demand within the regulated cannabis market. 

Challenges for Hemp-Based Businesses 

While the crackdown on hemp-derived cannabinoids could benefit traditional cannabis operators, it also introduces challenges for hemp-based businesses. The ambiguous and evolving nature of these regulations creates operational difficulties, especially in states that lack a clear definition of “psychoactive” or “intoxicating” hemp products. This regulatory ambiguity could lead to consumer confusion over which products are legally available, potentially complicating compliance for dispensaries that carry hemp-derived products. 

Another challenge is the reduced retail access that these regulations bring. Hemp products have historically enjoyed broader accessibility through venues such as convenience stores, gas stations, and online retailers—markets that licensed cannabis operators cannot typically access. As states impose new restrictions, licensed cannabis operators will need to navigate a more complex distribution landscape, which may include adapting product lines and reevaluating sales channels to avoid regulatory conflicts. 

Broader Market and Compliance Implications 

As hemp laws become more restrictive, the costs of compliance, product labeling, and testing will increase. Licensed cannabis operators already face high costs in maintaining compliance with strict state regulations, and with more laws potentially on the horizon, businesses may encounter heightened compliance expenses. Additionally, these new requirements may deter smaller operators from entering or staying in the market, potentially reducing competition but also limiting consumer options. 

Increased regulation of hemp-derived intoxicants may benefit traditional cannabis operators by reducing competition and enhancing consumer trust in regulated products. However, these advantages also present operational and regulatory challenges, necessitating that operators remain agile and informed as the landscape evolves. 

Chart of New Hemp Laws by State 

The following chart provides a clear overview of recent regulations and restrictions on hemp-derived products across various states. This visual representation allows industry stakeholders to quickly assess the legal landscape and understand how these laws impact the sale and distribution of hemp products.

State Law/Regulation Impacted Products 
Minnesota Limits THC content in hemp products to 0.3% Delta-8 THC, Delta-10 THC, and other cannabinoids 
Tennessee Bans sales of intoxicating hemp products Delta-8 THC, Delta-10 THC, THC-O 
North Carolina Implements age restrictions and compliance requirements All hemp-derived intoxicating products 
South Dakota Prohibits specific synthetic cannabinoids THC-O, Delta-8 THC, Delta-10 THC 
Louisiana Establishes THC content limits and age restrictions Delta-8 THC, Delta-10 THC, and similar products 
Iowa Bans intoxicating hemp products and sets labeling requirements All intoxicating hemp-derived products 
Nebraska Limits the sale of products with intoxicating effects Delta-8 THC, Delta-10 THC 
New York Requires rigorous testing and compliance for hemp products All hemp-derived intoxicating products 
Colorado Enforces new labeling and testing standards for hemp products Delta-8 THC, THC-O 
Oregon Bans sales of certain synthetic cannabinoids THC-O, Delta-8 THC 
Kentucky Sets strict THC limits and labeling requirements Delta-8 THC, Delta-10 THC 
Texas Proposes legislation to restrict intoxicating hemp products Delta-8 THC, Delta-10 THC 
California Bans hemp products with detectable THC; sets purchase age at 21.  Delta-8 THC, Delta-10 THC, and other intoxicating cannabinoids  
Illinois Proposes stricter rules on hemp products: age limits, potency caps, and testing. Delta-8 THC, Delta-10 THC, and other intoxicating cannabinoids  

This chart illustrates how states are taking varying approaches to regulate hemp products, often in response to public health concerns and market demand. As these regulations evolve, industry stakeholders must stay informed about changes that could impact their operations and the broader cannabis landscape. 

Final Thoughts

The recent state-by-state crackdown on hemp products marks a significant shift in the regulatory landscape for the cannabis industry. As states tighten regulations on hemp-derived intoxicants like Delta-8 THC and Delta-10 THC, traditional cannabis operators may benefit from reduced competition and increased consumer trust in licensed products. However, these changes also pose challenges, particularly for hemp-based businesses facing operational hurdles and compliance costs in this evolving environment.

Looking ahead, industry stakeholders must remain vigilant as the regulatory landscape continues to change. The interplay between state laws and potential future federal guidelines will shape the future of both the hemp and cannabis markets. Operators should prepare for ongoing adjustments to regulations, consumer preferences, and market dynamics, ensuring they remain adaptable and informed in an increasingly complex industry. Understanding these developments is critical for navigating the path forward and capitalizing on the opportunities that arise amidst the challenges of this crackdown.

Related Articles